3 years later, why don’t we know the extent of long COVID?
Amesh Adalja, MD, Principal Investigator, Johns Hopkins University Center for Health Security.
Manali Mukherjee, PhD, Immunologist, Assistant Professor, Division of Respirology, Department of Medicine, McMaster University.
Sarah Wulf Hanson, PhD, researcher, Institute for Health Metrics and Evaluation, University of Washington.
Lisa McCorkell, Co-Founder, Patient-Directed Research Collaboration.
Julia Moore Vogel, PhD, Program Director, Participant Center, All of Us Research Program, Scripps Research Translational Institute.
The BMJ: “Long COVID outcomes at one year after mild SARS-CoV-2 infection: nationwide cohort study.”
Nature Reviews Microbiology: “Long COVID: Main findings, mechanisms and recommendations.”
CDC National Center for Health Statistics: “COVID Household Long Pulse Survey.”
natural medicine: “Unexplained post-acute infectious syndromes.”
Patient-led research collaboration.
World Health Organization: “State post-COVID-19 (COVID long).”
CDC: “Post-COVID Conditions: CDC Science.”
The European Respiratory Journal: “Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long COVID symptoms.”
Emerging infectious diseases: “Postacute sequelae of SARS-CoV-2 in academia.”
International Consortium on Severe Acute Respiratory Infections and Emerging Infections (ISARIC): “Clinical Characterization Protocol (CCP)”.